rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-6-18
|
pubmed:abstractText |
There is an unmet clinical need for economic, minimally invasive procedures that use a limited number of cells for the molecular profiling of tumors in individual patients. Reverse-phase protein microarray (RPPM) technology has been applied successfully to the quantitative analysis of breast, ovarian, prostate, and colorectal cancers using frozen surgical specimens.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
111
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
173-84
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17487852-Bayes Theorem,
pubmed-meshheading:17487852-Biopsy, Fine-Needle,
pubmed-meshheading:17487852-Breast,
pubmed-meshheading:17487852-Breast Neoplasms,
pubmed-meshheading:17487852-Cell Line, Tumor,
pubmed-meshheading:17487852-Cluster Analysis,
pubmed-meshheading:17487852-Female,
pubmed-meshheading:17487852-Humans,
pubmed-meshheading:17487852-Microarray Analysis,
pubmed-meshheading:17487852-Phosphoproteins,
pubmed-meshheading:17487852-Protein Kinases,
pubmed-meshheading:17487852-Proteome,
pubmed-meshheading:17487852-Proteomics,
pubmed-meshheading:17487852-Reproducibility of Results
|
pubmed:year |
2007
|
pubmed:articleTitle |
The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology.
|
pubmed:affiliation |
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. rapkia01@med.nyu.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Intramural
|